| 000 | 01339 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516165036.0 | ||
| 264 | 0 | _c20140502 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1751-2441 | ||
| 024 | 7 |
_a10.1586/17512433.2013.828419 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMolimard, Mathieu | |
| 245 | 0 | 0 |
_aOnce-daily glycopyrronium via the Breezhaler® device for the treatment of COPD: pharmacological and clinical profile. _h[electronic resource] |
| 260 |
_bExpert review of clinical pharmacology _cSep 2013 |
||
| 300 |
_a503-17 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDry Powder Inhalers |
| 650 | 0 | 4 |
_aGlycopyrrolate _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aMuscarinic Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aD'Andrea, Peter | |
| 773 | 0 |
_tExpert review of clinical pharmacology _gvol. 6 _gno. 5 _gp. 503-17 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/17512433.2013.828419 _zAvailable from publisher's website |
| 999 |
_c23029168 _d23029168 |
||